J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
2,188.80
-37.65 (-1.69%)
At close: May 26, 2026
BOM:506943 Revenue
In the fiscal year ending March 31, 2026, J. B. Chemicals & Pharmaceuticals had annual revenue of 42.08B INR with 7.40% growth. J. B. Chemicals & Pharmaceuticals had revenue of 9.64B in the quarter ending March 31, 2026, a decrease of -2.37%.
Revenue
42.08B
Revenue Growth
+6.36%
P/S Ratio
8.40
Revenue / Employee
7.93M
Employees
5,304
Market Cap
353.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 42.08B | 2.90B | 7.40% |
| Mar 31, 2025 | 39.18B | 4.34B | 12.45% |
| Mar 31, 2024 | 34.84B | 3.35B | 10.63% |
| Mar 31, 2023 | 31.49B | 7.25B | 29.91% |
| Mar 31, 2022 | 24.24B | 3.82B | 18.69% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Reddy's Laboratories | 335.93B |
| Lupin | 279.58B |
| Jubilant Pharmova | 83.46B |
| Abbott India | 69.29B |
| Granules India | 53.66B |
| GlaxoSmithKline Pharmaceuticals | 38.22B |
| Viyash Scientific | 34.64B |
| Caplin Point Laboratories | 21.87B |
J. B. Chemicals & Pharmaceuticals News
- 2 days ago - JB Chemicals reports 35% of turnover from exports in FY26 - Business Upturn
- 15 days ago - J. B. Chemicals & Pharmaceuticals Transcript: Q4 25/26 - Transcripts
- 15 days ago - J. B. Chemicals & Pharmaceuticals Quarterly report: Q4 2026 - Filings
- 15 days ago - J. B. Chemicals & Pharmaceuticals Annual report: Q4 2026 - Filings
- 16 days ago - JB Chemicals reports Rs 904 crore revenue in Q4 FY26; net profit declines by 30% - Business Upturn
- 2 months ago - JB Chemicals calls shareholders' meeting under National Company Law Tribunal order - Business Upturn
- 2 months ago - Stocks to buy: What's the outlook for Nifty for March 23-27 week? Check list of top stock recommendations - The Times of India
- 2 months ago - JB Chemicals announces resignation of Sushree Mishra as General Manager - Business Upturn